LAWRENCE, Mass., Feb. 1 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, will participate in the Merrill Lynch Pharmaceutical, Biotechnology & Medical Device Conference. Mr. Burbank is scheduled to present an overview of the Company at 8:40 a.m. Eastern Time on Thursday, February 7, 2008 at The Grand Hyatt at Park Avenue in New York.
To listen to the audio web cast of the presentation during the event, please visit: http://www.nxstage.com and click on 'Investor Information.' A replay will be available for 14 days immediately following the live presentation.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at http://www.nxstage.com.
This release contains "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995. All statements
contained in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
|SOURCE NxStage Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved